Causes and consequences of quack medicine in health care: a scoping review of global experience.
Counterfeit medicine
Health service provision system
Quack medicine
Quackery in health care
Journal
BMC health services research
ISSN: 1472-6963
Titre abrégé: BMC Health Serv Res
Pays: England
ID NLM: 101088677
Informations de publication
Date de publication:
11 Jan 2024
11 Jan 2024
Historique:
received:
07
06
2023
accepted:
22
12
2023
medline:
12
1
2024
pubmed:
12
1
2024
entrez:
11
1
2024
Statut:
epublish
Résumé
The field of health has been facing challenges with fraudulent practices and the prevalence of "quack medicine". Many cases have given rise to this issue. Therefore, this study aims to comprehensively investigate and categorize the causes and consequences of quack medicine in the healthcare. A scoping review, using the 5 stages of Arksey and O'Malley's framework, was conducted to retrieve and analyze the literature. International databases including the PubMed, Scopus, Embase and Web of Science and also national Iranian databases were searched to find peer reviewed published literature in English and Persian languages. Grey literature was also included. Meta-Synthesis was applied to analyze the findings through an inductive approach. Out of 3794 initially identified studies, 30 were selected for this study. Based on the findings of this research, the causes of quackery in the health were divided into six categories: political, economic, socio-cultural, technical-organizational, legal and psychological. Additionally, the consequences of this issue were classified into three categories: health, economic and social. Economic and social factors were found to have a more significant impact on the prevalence of quackery in the health sector. Legal and technical-organizational factors played a crucial role in facilitating fraudulent practices, resulting in severe health consequences. It is evident that governing bodies and health systems must prioritize addressing economic and social factors in combating quackery in the health sector. Special attention should be paid to the issue of cultural development and community education to strengthen the mechanisms that lead to the society access to standard affordable services. Efforts should be made also to improve the efficiency of legislation, implementation and evaluation systems to effectively tackle this issue.
Sections du résumé
BACKGROUND
BACKGROUND
The field of health has been facing challenges with fraudulent practices and the prevalence of "quack medicine". Many cases have given rise to this issue. Therefore, this study aims to comprehensively investigate and categorize the causes and consequences of quack medicine in the healthcare.
METHODS
METHODS
A scoping review, using the 5 stages of Arksey and O'Malley's framework, was conducted to retrieve and analyze the literature. International databases including the PubMed, Scopus, Embase and Web of Science and also national Iranian databases were searched to find peer reviewed published literature in English and Persian languages. Grey literature was also included. Meta-Synthesis was applied to analyze the findings through an inductive approach.
RESULTS
RESULTS
Out of 3794 initially identified studies, 30 were selected for this study. Based on the findings of this research, the causes of quackery in the health were divided into six categories: political, economic, socio-cultural, technical-organizational, legal and psychological. Additionally, the consequences of this issue were classified into three categories: health, economic and social. Economic and social factors were found to have a more significant impact on the prevalence of quackery in the health sector. Legal and technical-organizational factors played a crucial role in facilitating fraudulent practices, resulting in severe health consequences.
CONCLUSION
CONCLUSIONS
It is evident that governing bodies and health systems must prioritize addressing economic and social factors in combating quackery in the health sector. Special attention should be paid to the issue of cultural development and community education to strengthen the mechanisms that lead to the society access to standard affordable services. Efforts should be made also to improve the efficiency of legislation, implementation and evaluation systems to effectively tackle this issue.
Identifiants
pubmed: 38212750
doi: 10.1186/s12913-023-10520-9
pii: 10.1186/s12913-023-10520-9
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
64Informations de copyright
© 2024. The Author(s).
Références
Joodaki H, Rashidian A. Review of corruption in the health Sector: theory, methods and interventions. Hospital. 2010;8(3):82–100.
Imran G, Tanu K. Why quacks thrive!‖. The Hindu. Volume 4. Bangalore; December. 2012.
Hammerschmidt DE. About the cover illustration: the quack doctor. J Lab Clin Med. 2005;146(6):352–3.
doi: 10.1016/j.lab.2005.11.002
pubmed: 16310519
Sudhinaraset M, Ingram M, Lofthouse HK, Montagu D. What is the role of informal healthcare providers in developing countries? A systematic review. PLoS ONE. 2013;8(2):e54978.
doi: 10.1371/journal.pone.0054978
pubmed: 23405101
pmcid: 3566158
Ballantine HT Jr. Medical quackery: medicine and chiropractic. Phys Ther. 1966;46(12):1322–6.
doi: 10.1093/ptj/46.12.1322
pubmed: 5957642
Ahmad S, Chaudary A, Shukla AK. A Burning Threat to Human’s Health from Quackery: A Review Study. Int J Contemp Pathol. 2017;3(1).
Dietz J, Gamble WB, Marchlowska J, Wheeler BT. Fighting health care Fraud in bold and innovative ways. Mil Med. 2013;178(10):1041–3.
doi: 10.7205/MILMED-D-13-00205
pubmed: 24083915
Kao A. Medical quackery: the pseudo-science of Health and Well-Being. AMA J Ethics. 2000;2(4):30–1.
Alam A. Fraudulent quacks putting patients’ life at risk: independent; 2020. Available from: https://www.theindependentbd.com/post/252957 .
Edwards IR. Fraudulent and substandard medicines: getting away with Murder? Drug Saf. 2011;34(6):445–8.
doi: 10.2165/11592370-000000000-00000
pubmed: 21585218
Substandard and falsified medical products 2018. Available from: https://www.who.int/news-room/fact-sheets/detail/substandard-and-falsified-medical-products .
McPake B, Asiimwe D, Mwesigye F, Ofumbi M, Ortenblad L, Streefland P, et al. Informal economic activities of public health workers in Uganda: implications for quality and accessibility of care. Soc Sci Med. 1999;49(7):849–65.
doi: 10.1016/S0277-9536(99)00144-6
pubmed: 10468391
Gupta S, Davoodi H, Tiongson E. Corruption and the provision of health care and education services. The political economy of corruption: Routledge; 2001. pp. 123–53.
Lewis M. Governance and corruption in public health care systems. Center for Global Development working paper. 2006(78).
Arora T, Sharma S. Global scenario of counterfeit antimalarials: a potential threat. J Vector Borne Dis. 2019;56(4):288–94.
doi: 10.4103/0972-9062.302030
pubmed: 33269727
Bernard VW. Why people become the victims of Medical Quackery. Am J Public Health Nation’s Health. 1965;55:1142–7.
doi: 10.2105/AJPH.55.8.1142
McMeekin JFDA, Insight. Health Fraud and COVID-19 2020. U.S. Food and Drug Administration (Web Site)]. Available from: https://www.fda.gov/news-events/fda-insight/fda-insight-health-fraud-and-covid-19 .
Munn Z, Peters MD, Stern C, Tufanaru C, McArthur A, Aromataris E. Systematic review or scoping review? Guidance for authors when choosing between a systematic or scoping review approach. BMC Med Res Methodol. 2018;18:1–7.
doi: 10.1186/s12874-018-0611-x
Arksey H, O’Malley L. Scoping studies: towards a methodological framework. Int J Soc Res Methodol. 2005;8(1):19–32.
doi: 10.1080/1364557032000119616
Shrivastava SRBL, Shrivastava PS, Ramasamy J. Public health measures to fight counterfeit medicine market. Int J Prev Med. 2014;5(3):370–1.
pubmed: 24829724
pmcid: 4018649
Jarvis WT, Quackery. The national council against health Fraud perspective. Rheumatic Disease Clinics of North America. 1999;25(4):805–14.
doi: 10.1016/S0889-857X(05)70101-0
pubmed: 10573757
Bagozzi D. World Health Organization steps up action against substandard and counterfeit medicines 2003. Available from: https://www.who.int/news/item/11-11-2003-world-health-organization-steps-up-action-against-substandard-and-counterfeit-medicines .
Kalb PE. Health care Fraud and abuse. JAMA. 1999;282(12):1163–8.
doi: 10.1001/jama.282.12.1163
pubmed: 10501120
About Be Safe Rx. 2020. Available from: https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/about-besaferx .
Miller A. Exposing medical Fraud: one of the last taboos in society. CMAJ: Can Med Association J = J de l’Association medicale canadienne. 2013;185(1):16–7.
doi: 10.1503/cmaj.109-4359
Stelfox HT, Redelmeier DA. An analysis of one potential form of health care Fraud in Canada. CMAJ. 2003;169(2):118–9.
pubmed: 12874158
pmcid: 164976
Avery LH. Congress focuses on health care Fraud and abuse. AORN J. 1996;63(1):269.
doi: 10.1016/S0001-2092(06)63465-0
pubmed: 9131116
Dear JW, Webb DJ. Disease mongering - A challenge for everyone involved in healthcare. Br J Clin Pharmacol. 2007;64(2):122–4.
doi: 10.1111/j.1365-2125.2006.02830.x
pubmed: 17214830
pmcid: 2000629
Iroegbulem VC. Disease Mongering: How Sickness Sells. 2020.
Cowart VS. Health Fraud’s toll: lost hopes, misspent billions. JAMA: The Journal of the American Medical Association. 1988;259(22):3229–30.
doi: 10.1001/jama.1988.03720220005004
pubmed: 3373653
Johnson GC, Gottesman RA. The health Fraud battle. Education is the best defense. Postgrad Med. 1989;85(8):289–90.
doi: 10.1080/00325481.1989.11700758
pubmed: 2726644
Hosseini SAR, Darbooy S, Tehrani Banihashemi SA, Naseri SM, Dinarvand R. Counterfeit medicines: report of a cross-sectional retrospective study in Iran. Public Health. 2011;125(3):165–71.
doi: 10.1016/j.puhe.2010.11.015
pubmed: 21397286
McCullough RR, Bosler B. An interview with Deputy Chief, Health Care Fraud Unit at the U.S. Attorney’s Office. Home Healthc now. 2015;33(10):560–2.
doi: 10.1097/NHH.0000000000000313
pubmed: 26529452
Know the Risks. 2013. Available from: https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/know-signs .
Lohsiriwat V, Lohsiriwat S. Fraud and deceit in published medical research. J Med Association Thail = Chotmaihet Thangphaet. 2007;90(10):2238–43.
Sparrow MK. Health care Fraud control: understanding the challenge. Journal of insurance medicine. (New York NY). 1996;28(2):86–96.
Jarvis W. Quackery: a national scandal. Clin Chem. 1992;38(8B Pt):1574–86.
pubmed: 1643742
Worrall RS. Detecting health Fraud in the field of learning disabilities. J Learn Disabil. 1990;23(4):207–12.
doi: 10.1177/002221949002300402
pubmed: 2094229
Akunyili DN, Nnani IPC. Risk of medicines: counterfeit Drugs. Int J Risk Saf Med. 2004;16(3):181–90.
Kasilo O, Boakye-Agyemang, WHO Regional Director for Africa 2014. We must prevent the production, marketing and use of unsafe medical products, says Dr Sambo,. Available from: https://www.afro.who.int/news/we-must-prevent-production-marketing-and-use-unsafe-medical-products-says-dr-sambo-who .
Nsimba SE. Problems associated with substandard and counterfeit Drugs in developing countries: a review article on global implications of counterfeit Drugs in the era of antiretroviral (ARVs) Drugs in a Free Market economy. East Afr J Public Health. 2008;5(3):205–10.
pubmed: 19374325
Dovlo D, Aboua F, Boakye-Agyemang C, Tesfaye LM, Desloovere P. Dr Moeti proposes actions to address fake medical products 2016. Available from: https://www.afro.who.int/news/dr-moeti-proposes-actions-address-fake-medical-products .
Berthelot J-M, Nizard J, Maugars Y. The negative Hawthorne effect: explaining pain overexpression. Joint Bone Spine. 2019;86(4):445–9.
doi: 10.1016/j.jbspin.2018.10.003
pubmed: 30316973
Price M, Norris DM. Health care Fraud: Physicians as white collar criminals? J Am Acad Psychiatry Law. 2009;37(3):286–9.
pubmed: 19767491
Miller A. Medical fraud north of the 49th. CMAJ: Canadian Medical Association journal = journal de l’Association medicale canadienne. 2013;185(1):E31–3.
Lindmeier C, Jasarevic T, Chaib F. Seventieth World Health Assembly update, 29 May 2017 2017. Available from: https://www.who.int/news/item/29-05-2017-seventieth-world-health-assembly-update-29-may-2017 .
Trapsida J-M, Ajibola ST, Etoa B, Koné S. Interventions for prevention and control of substandard/spurious/falsely labelled/falsified and/or counterfeit medical products in the WHO African Region 2010. Available from: https://www.afro.who.int/news/interventions-prevention-and-control-substandardspuriousfalsely-labelledfalsified-andor .
Widder RM, Anderson DC. The appeal of medical quackery: a rhetorical analysis. Res Social Administrative Pharmacy: RSAP. 2015;11(2):288–96.
doi: 10.1016/j.sapharm.2014.08.001
Pormann PE. The physician and the other: images of the charlatan in medieval Islam. Bull Hist Med. 2005:189–227.
Todman D. Galen (129–199). J Neurol. 2007;254(7):975.
doi: 10.1007/s00415-007-0625-5
pubmed: 17676358
Andriote J. Legal Drug Pushing: How Disease Mongers Keep Us All Doped Up. Essay The Atlantic. 2012.
Stowell NF, Schmidt M, Wadlinger N. Healthcare Fraud under the microscope: improving its prevention. J Financial Crime. 2018.
Shao J, Zhang Q, Ren Y, Li X, Lin T. Why are older adults victims of Fraud? Current knowledge and prospects regarding older adults’ vulnerability to Fraud. J Elder Abuse Negl. 2019;31(3):225–43.
doi: 10.1080/08946566.2019.1625842
pubmed: 31159679
Kovacs S, Hawes SE, Maley SN, Mosites E, Wong L, Stergachis A. Technologies for detecting falsified and substandard Drugs in low and middle-income countries. PLoS ONE. 2014;9(3):e90601.
doi: 10.1371/journal.pone.0090601
pubmed: 24671033
pmcid: 3966738
Wertheimer AI, Chaney NM, Santella T. Counterfeit pharmaceuticals: current status and future projections. J Am Pharmacists Association: JAPhA. 2003;43(6):710–7. quiz 7–8.
doi: 10.1331/154434503322642642
Li P, Yang Z. Accounting Fraud and prevention in listed companies in China. Int J Front Sociol. 2019;1(1).
Thahab FAAA. Legal measures to curb fraudulent online pharmacies in COVID-19 period. Int Res J Eng Technol (IRJET). 2020.
Alshahrani W, Alshahrani R, editors. Assessment of blockchain technology application in the improvement of pharmaceutical industry. 2021 international conference of women in data science At Taif University (WiDSTaif); 2021: IEEE.
Nicholas LH, Hanson C, Segal JB, Eisenberg MD. Association between treatment by Fraud and abuse perpetrators and health outcomes among Medicare beneficiaries. JAMA Intern Med. 2020;180(1):62–9.
doi: 10.1001/jamainternmed.2019.4771
pubmed: 31657838